QUARTA, ERIDE
 Distribuzione geografica
Continente #
NA - Nord America 1.438
AS - Asia 1.374
EU - Europa 1.253
SA - Sud America 218
AF - Africa 74
OC - Oceania 9
Totale 4.366
Nazione #
US - Stati Uniti d'America 1.384
SG - Singapore 504
IT - Italia 476
CN - Cina 263
VN - Vietnam 254
IE - Irlanda 201
BR - Brasile 165
SE - Svezia 111
HK - Hong Kong 109
DE - Germania 98
NL - Olanda 81
BD - Bangladesh 73
FR - Francia 70
ZA - Sudafrica 47
AT - Austria 40
GB - Regno Unito 36
FI - Finlandia 34
IN - India 32
RU - Federazione Russa 31
CA - Canada 29
TR - Turchia 25
AR - Argentina 22
MX - Messico 16
PL - Polonia 14
ID - Indonesia 13
KR - Corea 12
TW - Taiwan 12
EC - Ecuador 10
ES - Italia 9
IQ - Iraq 8
RS - Serbia 8
MY - Malesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
JP - Giappone 6
MA - Marocco 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
CI - Costa d'Avorio 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IR - Iran 5
JO - Giordania 5
UA - Ucraina 5
BE - Belgio 4
HR - Croazia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CL - Cile 3
GA - Gabon 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KY - Cayman, isole 1
LB - Libano 1
MM - Myanmar 1
MR - Mauritania 1
NG - Nigeria 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.366
Città #
Singapore 314
Ashburn 259
Dublin 197
San Jose 158
Parma 136
Dallas 110
Hong Kong 106
Chandler 97
Santa Clara 95
Ho Chi Minh City 74
Boardman 57
Hanoi 54
Beijing 52
Munich 52
Shanghai 51
Johannesburg 44
Milan 43
New York 39
Ann Arbor 38
Los Angeles 37
Groningen 33
Vienna 30
Lauterbourg 26
Rome 26
Bologna 25
Ferrara 22
Reggio Emilia 22
Turku 22
Hefei 21
Buffalo 18
Da Nang 17
Brooklyn 15
Council Bluffs 15
Haiphong 15
Chicago 13
Columbus 13
Hillsboro 13
Seattle 13
Frankfurt am Main 12
Guangzhou 12
Montreal 12
Princeton 12
Amsterdam 11
Helsinki 11
Stockholm 11
Warsaw 11
Des Moines 10
Moscow 10
Orem 10
Jakarta 9
Marseille 9
Mumbai 9
Nuremberg 9
Seoul 9
The Dalles 9
Ardea 8
Atlanta 8
Mexico City 8
São Paulo 8
Ankara 7
Houston 7
Istanbul 7
Tashkent 7
Thái Bình 7
Belgrade 6
Falls Church 6
London 6
Manchester 6
Phoenix 6
Taipei 6
West Jordan 6
Wilmington 6
Abidjan 5
Auckland 5
Bangkok 5
Buenos Aires 5
Denver 5
Fremont 5
Modena 5
Montegaldella 5
Naples 5
Ottawa 5
Padova 5
Puchong Batu Dua Belas 5
Segrate 5
Strasbourg 5
Amman 4
Assago 4
Brescia 4
Bắc Ninh 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Konyaalti 4
Macomer 4
Pune 4
Tokyo 4
Zagreb 4
Asunción 3
Belo Horizonte 3
Totale 2.787
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 229
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 228
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 203
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 191
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 164
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 163
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects 153
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 150
Respicell(TM): An innovative dissolution apparatus for inhaled products 150
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 149
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 146
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 134
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 134
Nasal delivery as a strategy for the prevention and treatment of COVID-19 134
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 134
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 128
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 127
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 127
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 123
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections 118
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 111
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 109
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 107
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation 103
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 103
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 101
LACTOBACILLI INHALATION POWDER FOR THE REDUCTION OF LUNG INFLAMMATION IN non-CF BRONCHIECTASIS DISEASE 97
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms 92
Understanding the importance of capsules in dry powder inhalers 89
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 79
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 72
Influence of Capsule Size and DPIs Resistance on Inhalable Dry Powder Aerodynamic Performance 32
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases 8
Inhalation drug products of loaded calcium phosphate nanoparticles for heart targeting 1
Totale 4.436
Categoria #
all - tutte 15.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022112 3 3 8 5 20 5 12 8 9 1 7 31
2022/2023430 36 49 19 33 27 43 30 35 129 11 9 9
2023/2024438 11 18 8 20 26 59 112 31 24 31 45 53
2024/2025939 28 42 67 101 75 80 79 58 96 72 85 156
2025/20262.381 178 137 313 240 320 142 262 92 327 157 144 69
Totale 4.436